Truist maintains Buy on Albemarle, cuts target to $245
Truist Securities analyst Peter Osterland maintained a Buy rating on Albemarle (NYSE: ALB) but lowered the price target to $245 from $260.

*this image is generated using AI for illustrative purposes only.
Truist Securities analyst Peter Osterland has maintained a Buy rating on Albemarle (NYSE: ALB) while adjusting the valuation outlook. The firm lowered the price target to $245, down from the previous target of $260.
The revision reflects a reassessment of the stock's potential, though the underlying bullish stance remains unchanged. Investors will note the reduced price target as the primary update in this assessment.
What specific factors led to the reassessment of Albemarle's valuation outlook?
How might this price target adjustment influence investor sentiment towards Albemarle in the short term?
What are the key catalysts that could drive Albemarle's stock toward the revised $245 target?


























